Cargando…

Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial

BACKGROUND: Sharing trial results with participants is an ethical imperative but often does not happen. We tested an Enhanced Webpage versus a Basic Webpage, Mailed Printed Summary versus no Mailed Printed Summary, and Email List Invitation versus no Email List Invitation to see which approach resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	South, Annabelle, Joharatnam-Hogan, Nalinie, Purvis, Cara, James, Elizabeth C., Diaz-Montana, Carlos, Cragg, William J., Tweed, Conor, Macnair, Archie, Sydes, Matthew R., Snowdon, Claire, Gillies, Katie, Isaacs, Talia, Bierer, Barbara E., Copas, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523080/ https://www.ncbi.nlm.nih.gov/pubmed/34606495 http://dx.doi.org/10.1371/journal.pmed.1003798

Ejemplares similares

Site staff perspectives on communicating trial results to participants: Cost and feasibility results from the Show RESPECT cluster randomised, factorial, mixed-methods trial
por: South, Annabelle, et al.
Publicado: (2023)

The role of aspirin in the prevention of ovarian, endometrial and cervical cancers
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
por: Lensen, Sarah, et al.
Publicado: (2020)

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study
por: Stenning, Sally P, et al.
Publicado: (2018)

Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies
por: South, Annabelle, et al.
Publicado: (2016)

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)

Erratum to: ‘Models and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies’
por: South, Annabelle, et al.
Publicado: (2016)

Accessing routinely collected health data to improve clinical trials: recent experience of access
por: Macnair, Archie, et al.
Publicado: (2021)

Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

When participants get involved: reconsidering patient and public involvement in clinical trials at the MRC Clinical Trials Unit at UCL
por: Vale, Claire L., et al.
Publicado: (2018)

Sharing data from clinical trials: the rationale for a controlled access approach
por: Sydes, Matthew R, et al.
Publicado: (2015)

A third trial oversight committee: Functions, benefits and issues
por: Lane, J Athene, et al.
Publicado: (2019)

Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2021)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

B-factory intermediate DC magnet power systems reliability modeling and results
por: Bellomo, P, et al.
Publicado: (2001)

A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis
por: Joharatnam, Nalinie, et al.
Publicado: (2015)

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system
por: Diaz-Montana, Carlos, et al.
Publicado: (2019)

Lack of transparent reporting of trial monitoring approaches in randomised controlled trials: A systematic review of contemporary protocol papers
por: Hsieh, Shao-Fan, et al.
Publicado: (2023)

Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis
por: McWilliams, Daniel F., et al.
Publicado: (2018)

REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
por: Merrick, Sophie, et al.
Publicado: (2023)

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
por: South, Annabelle, et al.
Publicado: (2016)

Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutum
por: Hempel, Franziska, et al.
Publicado: (2011)

Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms
por: Cragg, William J., et al.
Publicado: (2019)

Inclusion of Ethnic Minorities in Telehealth Trials for Type 2 Diabetes: Protocol for a Systematic Review Examining Prevalence and Language Issues
por: Edwards, Louisa, et al.
Publicado: (2016)

Separators for SLAC B-Factory
por: Petrichenkov, M V, et al.
Publicado: (2001)

Making a distinction between data cleaning and central monitoring in clinical trials
por: Love, Sharon B, et al.
Publicado: (2021)

Design, analysis and presentation of factorial randomised controlled trials
por: Montgomery, Alan A, et al.
Publicado: (2003)

Qualitative and mixed methods research in trials
por: Snowdon, Claire
Publicado: (2015)

Examining the language demands of informed consent documents in patient recruitment to cancer trials using tools from corpus and computational linguistics
por: Isaacs, Talia, et al.
Publicado: (2020)

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
por: Jankowski, Janusz A Z, et al.
Publicado: (2018)

Providing trial results to participants in phase III pragmatic effectiveness RCTs: a scoping review
por: Bruhn, Hanne, et al.
Publicado: (2021)

The Inclusion of Ethnic Minority Patients and the Role of Language in Telehealth Trials for Type 2 Diabetes: A Systematic Review
por: Isaacs, Talia, et al.
Publicado: (2016)

Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?*
por: Ziegler, Renatus
Publicado: (2009)

1716. Results of the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
por: Radonovich, Lewis, et al.
Publicado: (2018)

Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov
por: Muthukumar, Akila V., et al.
Publicado: (2021)

Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020)

LBA83 Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: A multi-centre North London experience
por: Nalinie Joharatnam-Hogan, N., et al.
Publicado: (2020)

Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
por: Love, Sharon B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tkscmbafmp8nppvti2aak11mh